×
Personalis Goodwill and Intangible Assets 2018-2025 | PSNL
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Personalis goodwill and intangible assets from 2018 to 2025. Goodwill and intangible assets can be defined as the sum of all intangible asset fields
View More
Personalis Goodwill and Intangible Assets 2018-2025 | PSNL
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Personalis goodwill and intangible assets from 2018 to 2025. Goodwill and intangible assets can be defined as the sum of all intangible asset fields
Related Stocks
Company Name
Market
Cap
Teva Pharmaceutical Industries (TEVA)
$18.8B
Dr Reddy's Laboratories (RDY)
$12.2B
BridgeBio Pharma (BBIO)
$9.1B
Bausch Health Cos (BHC)
$2.3B
Supernus Pharmaceuticals (SUPN)
$1.9B
Amphastar Pharmaceuticals (AMPH)
$1B
Taysha Gene Therapies (TSHA)
$567M
Assembly Biosciences (ASMB)
$144M
Sol-Gel Technologies (SLGL)
$23M
Evoke Pharma (EVOK)
$9M
Teligent (TLGT)
$0M